ConductScience.org, home

Paper39101201

Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial.

Tada A and 11 others. Circulation, 2024. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial. Papers, record 39101201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39101201

Download JSON
Disease
heart failure311 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial.
PubMed
Journal
Circulation
PubMed
Year
2024
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
6.2, provisional
iCite
Revised in PubMed
2025-09-25
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Benzhydryl CompoundsMajor topic
GlucosidesMajor topic
Heart FailureMajor topic
Stroke VolumeMajor topic
Sodium-Glucose Transporter 2 InhibitorsMajor topic
ExerciseMajor topic
Humans
Female
Aged
Male
Middle Aged
Compliance
Hemodynamics
Vascular Capacitance
Exercise Test
Blood Pressure

Source PubMed

Download CSV of topics

Grants15

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K23 HL164901NHLBI NIH HHSUnited StatesK23HL164901PubMedNIH RePORTER
R01 HL162828NHLBI NIH HHSUnited StatesR01HL162828PubMed and NIHNIH RePORTER
R01 HL155599NHLBI NIH HHSUnited StatesR01HL155599PubMed and NIHNIH RePORTER
R01 HL157108NHLBI NIH HHSUnited StatesR01HL157108PubMed and NIHNIH RePORTER
K24 AG070459NIA NIH HHSUnited StatesK24AG070459PubMed and NIHNIH RePORTER
R01 HL104106NHLBI NIH HHSUnited StatesR01HL104106PubMed and NIHNIH RePORTER
R01 AG058969NIA NIH HHSUnited StatesR01AG058969PubMed and NIHNIH RePORTER
R01 HL153646NHLBI NIH HHSUnited StatesR01HL153646PubMed and NIHNIH RePORTER
U01 HL160277NHLBI NIH HHSUnited StatesU01HL160277PubMed and NIHNIH RePORTER
R33 HL146390NHLBI NIH HHSUnited StatesR33HL146390PubMed and NIHNIH RePORTER
U01 HL160226NHLBI NIH HHSUnited StatesU01HL160226PubMed and NIHNIH RePORTER
UL1 TR001863NCATS NIH HHSUnited StatesUL1TR001863PubMedNIH RePORTER
R01 HL155764NHLBI NIH HHSUnited StatesR01HL155764PubMed and NIHNIH RePORTER
R01 HL128526NHLBI NIH HHSUnited StatesR01HL128526PubMed and NIHNIH RePORTER
U01 TR003734NCATS NIH HHSUnited StatesU01TR003734PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04730947Dapagliflozin (DAPA) Effects in HFpEFDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117620524Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model.Hypertension2007https://conductscience.org/library/papers/17620524PubMed
228039229Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study.Circulation2017https://conductscience.org/library/papers/28039229PubMed
335512865Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week.J Am Coll Cardiol2022https://conductscience.org/library/papers/35512865PubMed
434743533Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial.Circ Heart Fail2022https://conductscience.org/library/papers/34743533PubMed
511641312Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform.Hypertension2001https://conductscience.org/library/papers/11641312PubMed
633710924Personalized physiologic flow waveforms improve wave reflection estimates compared to triangular flow waveforms in adults.Am J Physiol Heart Circ Physiol2021https://conductscience.org/library/papers/33710924PubMed
724487087Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure.J Card Fail2014https://conductscience.org/library/papers/24487087PubMed
820733088Noninvasive evaluation of left ventricular afterload: part 2: arterial pressure-flow and pressure-volume relations in humans.Hypertension2010https://conductscience.org/library/papers/20733088PubMed
930764699Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction.J Am Heart Assoc2019https://conductscience.org/library/papers/30764699PubMed
1015699456Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension.Hypertension2005https://conductscience.org/library/papers/15699456PubMed
1122003052Use of the Frank-Starling mechanism during exercise is linked to exercise-induced changes in arterial load.Am J Physiol Heart Circ Physiol2012https://conductscience.org/library/papers/22003052PubMed
1237534453Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.Circulation2023https://conductscience.org/library/papers/37534453PubMed
1330060748Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.Cardiovasc Diabetol2018https://conductscience.org/library/papers/30060748PubMed
1434053158Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction.Eur J Heart Fail2021https://conductscience.org/library/papers/34053158PubMed
1514764438A novel framework of circulatory equilibrium.Am J Physiol Heart Circ Physiol2004https://conductscience.org/library/papers/14764438PubMed
1627354047Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction.Eur Heart J2016https://conductscience.org/library/papers/27354047PubMed
1711498648Load dependent diastolic dysfunction in heart failure.Heart Fail Rev2000https://conductscience.org/library/papers/11498648PubMed
189950841Use of pulse pressure method for estimating total arterial compliance in vivo.Am J Physiol1999https://conductscience.org/library/papers/9950841PubMed
1919114645Arthur C. Corcoran Memorial Lecture. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressure.Hypertension2009https://conductscience.org/library/papers/19114645PubMed
2031466622Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art Review.J Am Coll Cardiol2019https://conductscience.org/library/papers/31466622PubMed

See all 43 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42866227Bidirectional metabolic-vascular feedback loops in heart failure: From myocardial energetics to multisystem cardiometabolic crosstalk.iScience2026https://conductscience.org/library/papers/42866227PubMed
42842573Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study.PLoS One2026https://conductscience.org/library/papers/42842573PubMed
42770225Sotatercept Improves Right Heart Mechanics Despite Reduced Myocardial Contractility in Pulmonary Arterial Hypertension: A Prospective Exercise Hemodynamic Study.Circulation2026https://conductscience.org/library/papers/42770225PubMed
42518892Efficacy and Safety of SGLT2 Inhibitors and Sotagliflozin in Heart Failure: A Systematic Review and Meta-Analysis of 59 Randomized Controlled Trials.Cureus2026https://conductscience.org/library/papers/42518892PubMed
42291229Dapagliflozin binds PRMT7 to inhibit p38 MAPK phosphorylation and macrophage foam cell formation in atherosclerosis.iScience2026https://conductscience.org/library/papers/42291229PubMed
41888924Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial.Cardiovasc Diabetol2026https://conductscience.org/library/papers/41888924PubMed
41711198Effect of sodium-glucose cotransporter-2 inhibitors on haemoglobin and haematocrit levels in heart failure: a systematic review and meta-analysis.ESC Heart Fail2026https://conductscience.org/library/papers/41711198PubMed
41685452Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.Circulation2026https://conductscience.org/library/papers/41685452PubMed
41682651Preserved Ejection, Lost Rhythm: A Narrative Review of the Pathophysiology and Management of Heart Failure with Preserved Ejection Fraction and Concomitant Atrial Fibrillation.J Clin Med2026https://conductscience.org/library/papers/41682651PubMed
41677477Progression From Exercise-Induced to Resting Left Atrial Hypertension in HFpEF: Impact of Reduced Atriopulmonary Compliance.JACC Heart Fail2026https://conductscience.org/library/papers/41677477PubMed
41528276Implications of Potential Undiagnosed HFpEF on Symptomatic Response With Coronary Revascularization.JACC Heart Fail2026https://conductscience.org/library/papers/41528276PubMed
41093487Do Heart Failure With Preserved Ejection Fraction Treatments Work by Targeting Adipose Biology?J Am Coll Cardiol2025https://conductscience.org/library/papers/41093487PubMed
41045908Semaglutide and Exercise Function in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.JACC Heart Fail2025https://conductscience.org/library/papers/41045908PubMed
40968746SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI.ESC Heart Fail2025https://conductscience.org/library/papers/40968746PubMed
40925989Evaluation of pulmonary hypertension in heart failure with preserved ejection fraction.Heart Fail Rev2025https://conductscience.org/library/papers/40925989PubMed
40886173The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction: A Novel Framework to Explain Pathogenesis and Guide Treatment.J Am Coll Cardiol2025https://conductscience.org/library/papers/40886173PubMed
40796340Visceral adiposity, aortic stiffness, and cardiovascular risk.Eur J Prev Cardiol2026https://conductscience.org/library/papers/40796340PubMed
40668525Determinants of exercise tolerance in HFpEF: role of the heart versus the periphery.Heart Fail Rev2025https://conductscience.org/library/papers/40668525PubMed
40608855Physiologic Phenotyping of Responses to Exercise and Activity in Heart Failure.Circ Res2025https://conductscience.org/library/papers/40608855PubMed
40521197BCAA catabolism targeted therapy for heart failure with preserved ejection fraction.Theranostics2025https://conductscience.org/library/papers/40521197PubMed

See all 27 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
DAPAGLIFLOZINCHEMBL429910Derived from the trial1https://conductscience.org/library/drugs/CHEMBL429910

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39101201

GET https://conductscience.org/api/papers/v1/39101201/references?page=2